Selected research
Industry Growth & Trends
Global Romidepsin Industry Growth and Trends Forecast to 2032
Market perspective
The global Romidepsin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Romidepsin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Romidepsin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Romidepsin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Romidepsin include Santa Cruz Biotechnology, Inc., Shanghai Rechem science Co., Ltd., Shanghai lollane biological technology Co.,Ltd., Ningbo Inno Pharmchem Co., Ltd., Merck Group, Dalian Meilun Biotech Co., Ltd., TargetMol Chemicals Inc, Selleck Chemicals and InvivoChem LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Romidepsin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Romidepsin market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Romidepsin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Romidepsin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Romidepsin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Romidepsin Market by Company
Santa Cruz Biotechnology, Inc.
Shanghai Rechem science Co., Ltd.
Shanghai lollane biological technology Co.,Ltd.
Ningbo Inno Pharmchem Co., Ltd.
Merck Group
Dalian Meilun Biotech Co., Ltd.
TargetMol Chemicals Inc
Selleck Chemicals
InvivoChem LLC
Cckinase, Inc.
Cayman Chemical Company
BPS Bioscience, Inc.
Apexbio Technology LLC
AdooQ BioScience
Romidepsin Segment by Type
0.98
>98%
Romidepsin Segment by Application
Biological
Medical
Romidepsin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Romidepsin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Romidepsin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Romidepsin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Romidepsin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Romidepsin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.98
- >98%
Applications
- Biological
- Medical
Companies covered
- Santa Cruz Biotechnology, Inc.
- Shanghai Rechem science Co., Ltd.
- Shanghai lollane biological technology Co.,Ltd.
- Ningbo Inno Pharmchem Co., Ltd.
- Merck Group
- Dalian Meilun Biotech Co., Ltd.
- TargetMol Chemicals Inc
- Selleck Chemicals
- InvivoChem LLC
- Cckinase, Inc.
- Cayman Chemical Company
- BPS Bioscience, Inc.
- Apexbio Technology LLC
- AdooQ BioScience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Romidepsin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Romidepsin Sales Estimates and Forecasts (2021-2032)
- 1.3 Romidepsin Market by Type
- 1.3.1 0.98
- 1.3.2 >98%
- 1.4 Global Romidepsin Market Size by Type
- 1.4.1 Global Romidepsin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Romidepsin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Romidepsin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Romidepsin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Romidepsin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Romidepsin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Romidepsin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Romidepsin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Romidepsin Industry Trends
- 2.2 Romidepsin Industry Drivers
- 2.3 Romidepsin Industry Opportunities and Challenges
- 2.4 Romidepsin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Romidepsin Revenue (2021-2026)
- 3.2 Global Top Players by Romidepsin Sales (2021-2026)
- 3.3 Global Top Players by Romidepsin Price (2021-2026)
- 3.4 Global Romidepsin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Romidepsin Major Company Production Sites & Headquarters
- 3.6 Global Romidepsin Company, Product Type & Application
- 3.7 Global Romidepsin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Romidepsin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Romidepsin Players Market Share by Revenue in 2025
- 3.8.3 2025 Romidepsin Tier 1, Tier 2, and Tier 3
4 Romidepsin Regional Status and Outlook
- 4.1 Global Romidepsin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Romidepsin Historic Market Size by Region
- 4.2.1 Global Romidepsin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Romidepsin Sales in Value by Region (2021-2026)
- 4.2.3 Global Romidepsin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Romidepsin Forecasted Market Size by Region
- 4.3.1 Global Romidepsin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Romidepsin Sales in Value by Region (2027-2032)
- 4.3.3 Global Romidepsin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Romidepsin by Application
- 5.1 Romidepsin Market by Application
- 5.1.1 Biological
- 5.1.2 Medical
- 5.2 Global Romidepsin Market Size by Application
- 5.2.1 Global Romidepsin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Romidepsin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Romidepsin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Romidepsin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Romidepsin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Romidepsin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Romidepsin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Romidepsin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Santa Cruz Biotechnology, Inc.
- 6.1.1 Santa Cruz Biotechnology, Inc. Company Information
- 6.1.2 Santa Cruz Biotechnology, Inc. Business Overview
- 6.1.3 Santa Cruz Biotechnology, Inc. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Santa Cruz Biotechnology, Inc. Romidepsin Product Portfolio
- 6.1.5 Santa Cruz Biotechnology, Inc. Recent Developments
- 6.2 Shanghai Rechem science Co., Ltd.
- 6.2.1 Shanghai Rechem science Co., Ltd. Company Information
- 6.2.2 Shanghai Rechem science Co., Ltd. Business Overview
- 6.2.3 Shanghai Rechem science Co., Ltd. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shanghai Rechem science Co., Ltd. Romidepsin Product Portfolio
- 6.2.5 Shanghai Rechem science Co., Ltd. Recent Developments
- 6.3 Shanghai lollane biological technology Co.,Ltd.
- 6.3.1 Shanghai lollane biological technology Co.,Ltd. Company Information
- 6.3.2 Shanghai lollane biological technology Co.,Ltd. Business Overview
- 6.3.3 Shanghai lollane biological technology Co.,Ltd. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shanghai lollane biological technology Co.,Ltd. Romidepsin Product Portfolio
- 6.3.5 Shanghai lollane biological technology Co.,Ltd. Recent Developments
- 6.4 Ningbo Inno Pharmchem Co., Ltd.
- 6.4.1 Ningbo Inno Pharmchem Co., Ltd. Company Information
- 6.4.2 Ningbo Inno Pharmchem Co., Ltd. Business Overview
- 6.4.3 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Product Portfolio
- 6.4.5 Ningbo Inno Pharmchem Co., Ltd. Recent Developments
- 6.5 Merck Group
- 6.5.1 Merck Group Company Information
- 6.5.2 Merck Group Business Overview
- 6.5.3 Merck Group Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Merck Group Romidepsin Product Portfolio
- 6.5.5 Merck Group Recent Developments
- 6.6 Dalian Meilun Biotech Co., Ltd.
- 6.6.1 Dalian Meilun Biotech Co., Ltd. Company Information
- 6.6.2 Dalian Meilun Biotech Co., Ltd. Business Overview
- 6.6.3 Dalian Meilun Biotech Co., Ltd. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Dalian Meilun Biotech Co., Ltd. Romidepsin Product Portfolio
- 6.6.5 Dalian Meilun Biotech Co., Ltd. Recent Developments
- 6.7 TargetMol Chemicals Inc
- 6.7.1 TargetMol Chemicals Inc Company Information
- 6.7.2 TargetMol Chemicals Inc Business Overview
- 6.7.3 TargetMol Chemicals Inc Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 TargetMol Chemicals Inc Romidepsin Product Portfolio
- 6.7.5 TargetMol Chemicals Inc Recent Developments
- 6.8 Selleck Chemicals
- 6.8.1 Selleck Chemicals Company Information
- 6.8.2 Selleck Chemicals Business Overview
- 6.8.3 Selleck Chemicals Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Selleck Chemicals Romidepsin Product Portfolio
- 6.8.5 Selleck Chemicals Recent Developments
- 6.9 InvivoChem LLC
- 6.9.1 InvivoChem LLC Company Information
- 6.9.2 InvivoChem LLC Business Overview
- 6.9.3 InvivoChem LLC Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 InvivoChem LLC Romidepsin Product Portfolio
- 6.9.5 InvivoChem LLC Recent Developments
- 6.10 Cckinase, Inc.
- 6.10.1 Cckinase, Inc. Company Information
- 6.10.2 Cckinase, Inc. Business Overview
- 6.10.3 Cckinase, Inc. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Cckinase, Inc. Romidepsin Product Portfolio
- 6.10.5 Cckinase, Inc. Recent Developments
- 6.11 Cayman Chemical Company
- 6.11.1 Cayman Chemical Company Company Information
- 6.11.2 Cayman Chemical Company Business Overview
- 6.11.3 Cayman Chemical Company Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Cayman Chemical Company Romidepsin Product Portfolio
- 6.11.5 Cayman Chemical Company Recent Developments
- 6.12 BPS Bioscience, Inc.
- 6.12.1 BPS Bioscience, Inc. Company Information
- 6.12.2 BPS Bioscience, Inc. Business Overview
- 6.12.3 BPS Bioscience, Inc. Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 BPS Bioscience, Inc. Romidepsin Product Portfolio
- 6.12.5 BPS Bioscience, Inc. Recent Developments
- 6.13 Apexbio Technology LLC
- 6.13.1 Apexbio Technology LLC Company Information
- 6.13.2 Apexbio Technology LLC Business Overview
- 6.13.3 Apexbio Technology LLC Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Apexbio Technology LLC Romidepsin Product Portfolio
- 6.13.5 Apexbio Technology LLC Recent Developments
- 6.14 AdooQ BioScience
- 6.14.1 AdooQ BioScience Company Information
- 6.14.2 AdooQ BioScience Business Overview
- 6.14.3 AdooQ BioScience Romidepsin Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 AdooQ BioScience Romidepsin Product Portfolio
- 6.14.5 AdooQ BioScience Recent Developments
7 North America by Country
- 7.1 North America Romidepsin Sales by Country
- 7.1.1 North America Romidepsin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Romidepsin Sales by Country (2021-2026)
- 7.1.3 North America Romidepsin Sales Forecast by Country (2027-2032)
- 7.2 North America Romidepsin Market Size by Country
- 7.2.1 North America Romidepsin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Romidepsin Market Size by Country (2021-2026)
- 7.2.3 North America Romidepsin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Romidepsin Sales by Country
- 8.1.1 Europe Romidepsin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Romidepsin Sales by Country (2021-2026)
- 8.1.3 Europe Romidepsin Sales Forecast by Country (2027-2032)
- 8.2 Europe Romidepsin Market Size by Country
- 8.2.1 Europe Romidepsin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Romidepsin Market Size by Country (2021-2026)
- 8.2.3 Europe Romidepsin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Romidepsin Sales by Country
- 9.1.1 Asia-Pacific Romidepsin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Romidepsin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Romidepsin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Romidepsin Market Size by Country
- 9.2.1 Asia-Pacific Romidepsin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Romidepsin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Romidepsin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Romidepsin Sales by Country
- 10.1.1 South America Romidepsin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Romidepsin Sales by Country (2021-2026)
- 10.1.3 South America Romidepsin Sales Forecast by Country (2027-2032)
- 10.2 South America Romidepsin Market Size by Country
- 10.2.1 South America Romidepsin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Romidepsin Market Size by Country (2021-2026)
- 10.2.3 South America Romidepsin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Romidepsin Sales by Country
- 11.1.1 Middle East and Africa Romidepsin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Romidepsin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Romidepsin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Romidepsin Market Size by Country
- 11.2.1 Middle East and Africa Romidepsin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Romidepsin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Romidepsin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Romidepsin Value Chain Analysis
- 12.1.1 Romidepsin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Romidepsin Production Mode & Process
- 12.2 Romidepsin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Romidepsin Distributors
- 12.2.3 Romidepsin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst